Stroke Thrombectomy Selection

What Is ASPECTS in Stroke Thrombectomy Decisions?

The Alberta Stroke Program Early CT Score, or ASPECTS, was developed to help clinicians read early ischemic changes on noncontrast CT in anterior-circulation stroke. A score of 10 suggests no visible early ischemic change, while lower scores suggest more extensive injury. For years, many treatment pathways used low ASPECTS values as a reason to avoid endovascular thrombectomy because larger infarcts were thought to carry less benefit and more risk.

The limitation is that ASPECTS is a visual estimate, not a full biological picture of the stroke. It does not fully capture collateral blood flow, infarct growth speed, perfusion mismatch, clot location, pre-stroke function, or the time course of symptoms. That is why the current debate matters: a single CT score may underestimate the chance of benefit in some patients whose brain tissue is injured but not yet irreversibly lost.

Why Can Some Low-ASPECTS Stroke Patients Still Benefit?

Large-core stroke trials including RESCUE-Japan LIMIT, SELECT2, and ANGEL-ASPECT changed the field by testing thrombectomy in patients previously considered outside the safest evidence base. These studies did not show that every severe stroke should undergo a procedure; rather, they showed that selected patients with large-vessel occlusion and substantial ischemic change can still benefit when imaging and clinical criteria support treatment.

Endovascular thrombectomy works by physically removing a clot from a blocked brain artery, usually through a catheter inserted from the groin or wrist. Its benefit depends on restoring blood flow before the ischemic core expands too far. Advanced CT perfusion, MRI diffusion-perfusion imaging, CT angiography, and collateral assessment can help stroke teams decide whether the remaining at-risk tissue is likely to be salvageable.

How Could This Change Emergency Stroke Treatment?

The practical message is not to delay care for more scans, but to use rapid imaging more intelligently. Current stroke systems already emphasize speed because treatment benefit falls as time passes. For eligible patients, thrombectomy is standard within the early treatment window, and selected patients can be treated up to 24 hours after last known well based on advanced imaging criteria established by trials such as DAWN and DEFUSE 3.

For patients and families, the key point is that emergency evaluation at a stroke-capable hospital is essential. Symptoms such as face drooping, arm weakness, speech trouble, sudden vision loss, or severe sudden imbalance should prompt emergency services immediately. Once in the stroke pathway, specialists can weigh ASPECTS alongside vessel imaging, infarct size, bleeding risk, disability before stroke, and the patient’s overall likelihood of meaningful recovery.